A New Nutritional Countermeasure to Prevent the Deconditioning Induced by 60 Days of Antiorthostatic Bed Rest
NCT ID: NCT03594799
Last Updated: 2021-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2016-09-01
2020-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Sixteen scientific protocols will assess the changes in the cardiovascular, metabolism, muscle, bone, neuro sensorial, hematological and immunology systems.
* In the above mentioned systems, the potential beneficial effects of the countermeasure protocol will also be investigated.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Nutrient Cocktail to Protect Against Physical Inactivity
NCT03313869
Effect of Antioxidant Vitamins on Coagulopathy and Nosocomial Pneumonia After Severe Trauma
NCT01897792
How Does Altering the Timing of Pre-exercise Low-dose Caffeine Ingestion Affect Endurance Exercise Performance
NCT02985606
Nutritional Intervention to Enhance Sleep Quality and Quantity in Athletes
NCT05032729
Effects of a Recovery Supplement on Body Composition, Performance, Muscular Properties, and Wellbeing
NCT05769101
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Based on recent evidences, the next countermeasure to be tested during a 60-day bed rest includes a nutritional countermeasure composed of an anti-oxidant and anti-inflammatory dietary mix.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bed Rest Control Group
60 days of strict head-down tilt bed rest
Bed Rest Control Group
Subjects are in strict head down tilt bed rest at all time (including for taking showers etc.) for 60 days.
Cocktail intervention
60 days of strict head-down tilt bed rest along with a Cocktail supplementation composed of natural antioxidants XXS-2A-BR2 comprising vitamin E, Selenium and coupled with omega-3
Cocktail intervention
Subjects are in strict head down tilt bed rest at all time (including for taking showers etc.) for 60 days. In addition subjects are receiving a daily supplementation of a Cocktail. The daily dose of Cocktail consists of 6 pills per day: 2 at breakfast, 2 at lunch and 2 at diner. This will be equivalent to a daily dose of around 741 mg of bioactive polyphenols associated with Omega-3, Selenium and Vitamine E.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Bed Rest Control Group
Subjects are in strict head down tilt bed rest at all time (including for taking showers etc.) for 60 days.
Cocktail intervention
Subjects are in strict head down tilt bed rest at all time (including for taking showers etc.) for 60 days. In addition subjects are receiving a daily supplementation of a Cocktail. The daily dose of Cocktail consists of 6 pills per day: 2 at breakfast, 2 at lunch and 2 at diner. This will be equivalent to a daily dose of around 741 mg of bioactive polyphenols associated with Omega-3, Selenium and Vitamine E.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 20 to 45,
* No overweight nor excessive thinness with BMI (weight Kg/ height m2) between 22 and 27,
* Height between 158 and 190 cm,
* No personal nor family past record of chronic or acute disease or psychological disturbances which could affect the physiological data and/or create a risk for the subject during the experiment,
* Fitness level assessment:
* if age \< 35 years: 35 ml/min./kg \< VO2max \< 60ml/min./kg,
* if age \> 35 years: 30 ml/min./kg \< VO2max \< 60ml/min./kg
* Active and free from any orthopedic, musculoskeletal and cardiovascular disorders,
* Non smokers,
* No alcohol, no drug dependence and no medical treatment,
* No shift work or travel across more than one time zone in previous 2 months,
* Covered by a Social Security system,
* Have signed the information consent,
* Free of any engagement during the three hospitalization planned periods.
Exclusion Criteria
* Cardiac rhythm disorders,
* Chronic back pains,
* History of hiatus hernia or gastro-esophageal reflux,
* History of thyroid dysfunction, renal stones, diabetes, migraines,
* Past records of thrombophlebitis, family history of thrombosis or positive response in thrombosis screening procedure,
* Allergy including xylocaine allergy
* Abnormal result for lower limbs echo-doppler,
* History or active claustrophobia,
* History of genetic muscle and bone diseases of any kind,
* History of sleep disorders, no shift work or travel across more than one time zone in previous two months
* Vestibular disorders,
* Audition problem,
* Vision corrected no more than 20/30, color-blindness
* Bone mineral density: T-score ≤ -1.5,
* Osteosynthesis material, presence of metallic implants,
* History of knee problems or joint surgery/broken leg
* Poor tolerance to blood sampling,
* Having given blood (more than 8ml/kg) in a period of 8 weeks or less before the start of the experiment,
* Special food diet, vegetarian or vegan, food allergy especially allergic to peanut or soya.
* Positive reaction to any of the following tests: HVA IgM (hepatitis A), HBs antigen (hepatitis B), anti-HVC antibodies (hepatitis C), anti-HIV1+2 antibodies,
* Subject already participating or in the exclusion period of a clinical research,
* Refusal to give permission to contact his general practitioner,
* Incarcerated persons,
* Subject who, in the judgment of the investigator, is likely to be non-compliant during the study, or unable to cooperate because of a language problem or poor mental development,
* Subject who has received more than 4500 Euros within 12 months for being a research subject.
* Subject under guardianship or trusteeship.
20 Years
45 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Space Agency
OTHER
Centre National d'Etudes Spatiales
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Arnaud BECK, MD
Role: PRINCIPAL_INVESTIGATOR
MEDES - IMPS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medes-Imps
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Trim WV, Walhin JP, Koumanov F, Turner JE, Shur NF, Simpson EJ, Macdonald IA, Greenhaff PL, Thompson D. The impact of physical inactivity on glucose homeostasis when diet is adjusted to maintain energy balance in healthy, young males. Clin Nutr. 2023 Apr;42(4):532-540. doi: 10.1016/j.clnu.2023.02.006. Epub 2023 Feb 16.
Stratis D, Trudel G, Rocheleau L, Pelchat M, Laneuville O. The Characteristic Response of the Human Leukocyte Transcriptome to 60 Days of Bed Rest and to Reambulation. Med Sci Sports Exerc. 2023 Mar 1;55(3):365-375. doi: 10.1249/MSS.0000000000003071. Epub 2022 Oct 15.
Trim WV, Walhin JP, Koumanov F, Bouloumie A, Lindsay MA, Travers RL, Turner JE, Thompson D. The Impact of Long-term Physical Inactivity on Adipose Tissue Immunometabolism. J Clin Endocrinol Metab. 2022 Jan 1;107(1):177-191. doi: 10.1210/clinem/dgab647.
Austermann K, Baecker N, Zwart SR, Fimmers R, Frippiat JP, Stehle P, Smith SM, Heer M. Antioxidant Supplementation Does Not Affect Bone Turnover Markers During 60 Days of 6 degrees Head-Down Tilt Bed Rest: Results from an Exploratory Randomized Controlled Trial. J Nutr. 2021 Jun 1;151(6):1527-1538. doi: 10.1093/jn/nxab036.
Liu T, Melkus G, Ramsay T, Sheikh A, Laneuville O, Trudel G. Bone Marrow Reconversion With Reambulation: A Prospective Clinical Trial. Invest Radiol. 2021 Apr 1;56(4):215-223. doi: 10.1097/RLI.0000000000000730.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14-981
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.